Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication. | bioRxiv | 2023 | 37609256 | PubTator, text mining | PubMed |
| The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma. | Diagn Pathol | 2023 | 37608295 | PubTator, text mining | PubMed |
| Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. | FASEB J | 2023 | 37606566 | PubTator, text mining | PubMed |
| In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases. | Neurol Int | 2023 | 37606395 | PubTator, text mining | PubMed |
| Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration. | Cureus | 2023 | 37605676 | PubTator, text mining | PubMed |
| m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway. | J Exp Clin Cancer Res | 2023 | 37605223 | PubTator, text mining | PubMed |
| miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis. | Sci Rep | 2023 | 37604948 | PubTator, text mining | PubMed |
| Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity. | Aging (Albany NY) | 2023 | 37602882 | PubTator, text mining | PubMed |
| RNA N6‑methyladenosine methyltransferase WTAP promotes the differentiation of endothelial progenitor cells. | Exp Ther Med | 2023 | 37602313 | PubTator, text mining | PubMed |
| The integrated stress response in cancer progression: a force for plasticity and resistance. | Front Oncol | 2023 | 37601686 | PubTator, text mining | PubMed |
| Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants. | Front Endocrinol (Lausanne) | 2023 | 37600717 | PubTator, text mining | PubMed |
| Research progress of circRNA in malignant tumour metabolic reprogramming. | RNA Biol | 2023 | 37599427 | PubTator, text mining | PubMed |
| The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma. | Mol Biol Rep | 2023 | 37598390 | PubTator, text mining | PubMed |
| m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia. | BMC Med Genomics | 2023 | 37596597 | PubTator, text mining | PubMed |
| m6A methylation: a potential key player in understanding and treating COVID-2019 infection. | Cell Death Discov | 2023 | 37596265 | PubTator, text mining | PubMed |
| Circ_0067934: a circular RNA with roles in human cancer. | Hum Cell | 2023 | 37592109 | PubTator, text mining | PubMed |
| Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells. | Open Med (Wars) | 2023 | 37588656 | PubTator, text mining | PubMed |
| Characterization of the skin keloid microenvironment. | Cell Commun Signal | 2023 | 37587491 | PubTator, text mining | PubMed |
| ALKBH5 inhibitors as a potential treatment strategy in heart failure-inferences from gene expression profiling. | Front Cardiovasc Med | 2023 | 37583580 | PubTator, text mining | PubMed |
| m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. | Mol Cancer | 2023 | 37582735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=44